CA970377A - Benzonaphthyridine derivatives - Google Patents

Benzonaphthyridine derivatives

Info

Publication number
CA970377A
CA970377A CA112,767A CA112767A CA970377A CA 970377 A CA970377 A CA 970377A CA 112767 A CA112767 A CA 112767A CA 970377 A CA970377 A CA 970377A
Authority
CA
Canada
Prior art keywords
benzonaphthyridine derivatives
benzonaphthyridine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA112,767A
Other languages
English (en)
Inventor
Hans Ott
Rudolf Suess
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz Patent Ltd
Original Assignee
Sandoz Patent Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH708670A external-priority patent/CH527196A/de
Priority claimed from CH708970A external-priority patent/CH527822A/de
Application filed by Sandoz Patent Ltd filed Critical Sandoz Patent Ltd
Application granted granted Critical
Publication of CA970377A publication Critical patent/CA970377A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA112,767A 1970-05-13 1971-05-12 Benzonaphthyridine derivatives Expired CA970377A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH708670A CH527196A (de) 1970-05-13 1970-05-13 Verfahren zur Herstellung neuer Benzonaphthyridinderivate
CH708970A CH527822A (de) 1970-05-13 1970-05-13 Verfahren zur Herstellung neuer Benzonaphtyridin-Derivate

Publications (1)

Publication Number Publication Date
CA970377A true CA970377A (en) 1975-07-01

Family

ID=25700728

Family Applications (1)

Application Number Title Priority Date Filing Date
CA112,767A Expired CA970377A (en) 1970-05-13 1971-05-12 Benzonaphthyridine derivatives

Country Status (14)

Country Link
JP (1) JPS5432799B1 (OSRAM)
AT (1) AT326674B (OSRAM)
CA (1) CA970377A (OSRAM)
CS (2) CS162753B2 (OSRAM)
DE (1) DE2123328A1 (OSRAM)
DK (1) DK134488B (OSRAM)
ES (1) ES391026A1 (OSRAM)
FI (1) FI52089C (OSRAM)
FR (1) FR2100649B1 (OSRAM)
GB (1) GB1361441A (OSRAM)
NL (1) NL7106502A (OSRAM)
PL (1) PL76913B1 (OSRAM)
SE (1) SE387640B (OSRAM)
SU (1) SU423296A3 (OSRAM)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899494A (en) * 1970-05-13 1975-08-12 Sandoz Ltd Substituted 6-phenyl benzo-naphthyridines
NL7314396A (OSRAM) * 1972-10-26 1974-05-01
BE880455A (fr) * 1979-01-22 1980-06-06 Sandoz Sa Compositions pharmaceutiques a base d'une benzo (c) (1,6) naphtyridine
ATE232864T1 (de) 1997-06-03 2003-03-15 Altana Pharma Ag Benzonaphthyridine
AU777012B2 (en) 1999-08-21 2004-09-30 Takeda Gmbh Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonist
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
WO2004087211A2 (en) 2003-04-01 2004-10-14 Applied Research Systems Ars Holding N.V. Inhibitors of phosphodiesterases in infertility
MXPA06013162A (es) * 2004-05-12 2007-02-13 Pfizer Prod Inc Derivados de piperidina como antagonistas de neurocinina 1 y neurocinina 3.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX2009013293A (es) 2007-06-04 2010-02-15 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos.
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
ES2664873T3 (es) 2011-03-01 2018-04-23 Synergy Pharmaceuticals Inc. Proceso de preparación de agonistas de guanilato ciclasa C
EP3718557A3 (en) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
HK1220696A1 (zh) 2013-03-15 2017-05-12 Bausch Health Ireland Limited 鸟苷酸环化酶激动剂及其用途
KR102272746B1 (ko) 2013-06-05 2021-07-08 보슈 헬스 아일랜드 리미티드 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법
AU2014305843B2 (en) 2013-08-09 2019-08-29 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport

Also Published As

Publication number Publication date
NL7106502A (OSRAM) 1971-11-16
ES391026A1 (es) 1974-04-01
FR2100649B1 (OSRAM) 1974-08-30
SU423296A3 (ru) 1974-04-05
DK134488C (OSRAM) 1977-05-16
FR2100649A1 (OSRAM) 1972-03-24
FI52089C (fi) 1977-06-10
SE387640B (sv) 1976-09-13
CS167202B2 (OSRAM) 1976-04-29
AT326674B (de) 1975-12-29
DE2123328A1 (de) 1971-12-02
GB1361441A (en) 1974-07-24
JPS5432799B1 (OSRAM) 1979-10-16
PL76913B1 (en) 1975-02-28
FI52089B (OSRAM) 1977-02-28
ATA412471A (de) 1975-03-15
DK134488B (da) 1976-11-15
CS162753B2 (OSRAM) 1975-07-15

Similar Documents

Publication Publication Date Title
CA970377A (en) Benzonaphthyridine derivatives
AU451793B2 (en) Pyridoquinoline derivatives
AU453008B2 (en) Triazolobenzodiazepine derivatives
AU466630B2 (en) Ergolene derivatives
CA970378A (en) Pyridoindole derivatives
CA1014574A (en) Phenylisopropylamine derivatives
CA943551A (en) Pyridoindole derivatives
AU444009B2 (en) Triazolobenzodiazepine 5n-oxide derivatives
AU453566B2 (en) Basic thienylalkane derivatives
AU3306971A (en) Leucauramine derivatives
AU446117B2 (en) Dihydropyrimidopyridazine derivatives
AU2648271A (en) 2-amino-imidazol-2-ine derivatives
AU444558B2 (en) BASIC b-THIENYL DERIVATIVES
AU443255B2 (en) Evomonoside derivatives
CA834197A (en) 6-phenylbenzazolyl derivatives
CA839728A (en) Bis-isoquinolinium derivatives
CA838134A (en) Dianisylimidazole derivatives
AU439043B2 (en) Puridazone derivatives
AU442249B2 (en) Terahydrocyclopropadibenzazepine derivatives
CA838131A (en) Benzepine derivatives
CA837631A (en) Sulfonamidoindole derivatives
AU444748B2 (en) Aryloxyalkylmorpholine derivatives
CA837137A (en) Penta-chlorobenzylidenamine derivatives
AU448024B2 (en) Phenylaklane derivatives
AU448194B2 (en) Dibenzothiopene derivatives